Literature DB >> 30965278

Responses of biomarkers belonging to different metabolic systems of rats following oral administration of aluminium nanoparticle.

Esin G Canli1, Hasan Basri Ila2, Mustafa Canli2.   

Abstract

Nanoparticle (NP) forms of aluminium oxide (Al2O3) are used in various fields such as engineering, pharmacy, medicine etc. Compounds containing aluminium oxide NPs may present toxic effects after certain thresholds. Thus, the present study was carried out to determine the effects of Al2O3 nanoparticles (Al-NPs) in rats. For this aim, different doses (0, 0.5, 5, 50 mg/kg b.w./day) of Al NP (˜40 nm) were orally administered to female rats (Rattus norvegicus var. albinus) for 14 days and the response of several biomarkers such as activities of ATPases (total ATPase, Na,K-ATPase, Mg-ATPase) and acetylcholinesterase (AChE), levels of different glutathione forms and thiobarbituric acid reactive substances (TBARS) were measured in different tissues. Additionally, tissue accumulation of Al-NPs was demonstrated by a transmission electron microscope (TEM). The images showed the presence of Al-NP aggregates in all the tissues at all doses. The sizes of NP aggregates were dependent on NP doses and it was a bit more loose in the brain than in the liver and kidney. AChE activity in the brain decreased significantly at all NP doses, whereas TBARS levels in the liver did not alter significantly at any NP dose. Although there was no significant change in ATPase activities in the intestine at any NP dose, there were significant decreases in the kidney and brain. There were some variations in the levels of total glutathione (tGSH), oxidized glutathione (GSSG) and reduced glutathione (rGSH), though these variations were not significant (P > 0.05). Likewise, the ratio of rGSH/GSSG also did not differ significantly among NP doses and control. The brain seems most affected organ following Al-NP administration. This study demonstrated that most biomarkers in the tissues of rats were affected by Al-NP, showing the signal of toxic effects and suggests further studies to understand better the effects of Al NPs, especially in their use for pharmacology.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aluminium oxide; Biomarker; Metal; Nanoparticle; Rat; TEM

Mesh:

Substances:

Year:  2019        PMID: 30965278     DOI: 10.1016/j.etap.2019.04.002

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  4 in total

1.  Involvement of Mitophagy in Primary Cultured Rat Neurons Treated with Nanoalumina.

Authors:  Lan Zhang; Jinjin Zhao; Xinyue Guo; Cuicui Ge; Lijun Chang; Xiaocheng Gao; Tao Huang; Yanhong Wang; Nan Shang; Qiao Niu; Qinli Zhang
Journal:  Neurotox Res       Date:  2022-08-09       Impact factor: 3.978

2.  Biodistribution, cardiac and neurobehavioral assessments, and neurotransmitter quantification in juvenile rats following oral administration of aluminum oxide nanoparticles.

Authors:  Ninell P Mortensen; Maria Moreno Caffaro; Purvi R Patel; Rodney W Snyder; Scott L Watson; Shyam Aravamudhan; Stephanie A Montgomery; Timothy Lefever; Susan J Sumner; Timothy R Fennell
Journal:  J Appl Toxicol       Date:  2020-12-02       Impact factor: 3.628

3.  Genotoxicity of Aluminum and Aluminum Oxide Nanomaterials in Rats Following Oral Exposure.

Authors:  Pégah Jalili; Sylvie Huet; Rachelle Lanceleur; Gérard Jarry; Ludovic Le Hegarat; Fabrice Nesslany; Kevin Hogeveen; Valérie Fessard
Journal:  Nanomaterials (Basel)       Date:  2020-02-11       Impact factor: 5.076

4.  Aluminium oxide nanoparticles compromise spatial memory performance and proBDNF-mediated neuronal function in the hippocampus of rats.

Authors:  Wei Sun; Jia Li; Xiaoliang Li; Xiao Chen; Yazi Mei; Yang Yang; Lei An
Journal:  Part Fibre Toxicol       Date:  2022-05-10       Impact factor: 9.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.